Recently completed_ongoing randomised trials of CSC-targeted therapies_2

BSC=best supportive care; carbo=carboplatin; CRC=colorectal cancer; AE= most severe adverse effect; etop=etoposide; GEJ=gastroesophageal junction; gem=gemcitabine; nab-p=nab-paclitaxel; NSCLC=non-small cell lung cancer; SCLC=small cell lung cancer. Table adapted (and modified to reflect current trial status) from [27].